west virginia glp-1 pancreatitis lawsuit West Virginia revealed as the

iBio may have the best R/R in myostatin inhibition, but the market hasn't realized it is no longer a struggling immuno-oncology company.

Promotes metabolism and energy burning

The pharmacy benefit manager announced it will cover Lillys Foundayo starting June 1 and Zepbound starting in October, a setback of sorts for rival Novo Nordisk as Wegovy has been preferred.

At the Fortune Innovation Forum, our founder and CEO, Dr

In this article, we explore the role and therapeutic potential of these well-established obesity drug targets

Visual presentation of new weight loss medicine trial results can supplement standard published reports by condensing substantial amounts of complex technical information in an easily understood format that can potentially yield new study insights.